Thanks to your generosity, LuMind Research Down Syndrome has $17 million in grants to leading academic institutions. The grants we’ve made with your donations, have ignited exciting new discoveries, engaged new researchers to study Down syndrome, and seen unprecedented speed to clinical trials.
2017-18 Grant Awards
Learning Through Objects in Infants and Toddlers with Down Syndrome: Vanderbilt University, Principal Investigator Amy Needham, PhD
Disomic and trisomic pluripotent stem cell (iPSC) to study pharmacologic intervention affecting gene expression patterns in other chromosomes: MIT – Tsai Laboratory, Principal Investigator Hiruy Meharena, PhD
Trisomy 21 Dosage Correction and Mapping Resource (T21DoCoMap) and XIST silencing in mature neurons: U Conn Health, Principal Investigator Stefan Pinter, PhD
A Phase Ib Multi-Center, Double-Blind, Randomized, Placebo-Controlled Dose Escalation Study of the Safety, Tolerability and Immunogenicity of ACI-24 in Adults with Down Syndrome: AC Immune and UC San Diego School of Medicine,
Principal Investigators Wolgang Barth, PhD and Michael Raffi, MD, PhD
Defining genes, mechanisms and treatments for neurodevelopmental and neurodegenerative causes of cognitive dysfunction in Down syndrome: UC San Diego School of Medicine, Principal Investigator William Mobley, MD, PhD
Brain development, sleep and learning in Down syndrome: University of Arizona, Principal Investigator Jamie Edgin, PhD
A next generation mouse model for trisomy 21 that mimics findings from human brain and CSF: Johns Hopkins University School of Medicine, Principal Investigator Roger Reeves, PhD
The Down Syndrome Cognition Project: Emory University, Principal Investigator Stephanie Sherman, PhD
Sleep, Circadian, and Stem Cell Renewal Factors in the Learning Disability of Down Syndrome: Stanford University, Principal Investigators H. Craig Heller, PhD and Maddalena Adorno, PhD
Key Opinion Leader (KOL) Meetings on Latest Advances in LuMind RDS’ Four Scientific Research Categories – Many participants, from a range of universities, organizations, government, industry players and institutes.